What is true of tamoxifen: A. It can induce endometrial proliferation in postmenopausal women B. It exerts antiestrogenic activity in bone C. It raises LDL-cholesterol levels D. It is ineffective in estrogen receptor-negative breast cancer

What is true of tamoxifen:
A. It can induce endometrial proliferation in
postmenopausal women
B. It exerts antiestrogenic activity in bone
C. It raises LDL-cholesterol levels
D. It is ineffective in estrogen receptor-negative
breast cancer
by

1 Answer

Answer :

A. It can induce endometrial proliferation in
postmenopausal women
by

Related questions

The following effect(s) of tamoxifen citrate indicate(s) that it possesses tissue specific estrogenic action as well: A. Inhibition of breast cancer cells B. Endometrial proliferation C. Hot flushes in premenopausal women D. All of the above

Description : The following effect(s) of tamoxifen citrate indicate(s) that it possesses tissue specific estrogenic action as well: A. Inhibition of breast cancer cells B. Endometrial proliferation C. Hot flushes in premenopausal women D. All of the above

Last Answer : B. Endometrial proliferation

Estrogen therapy in postmenopausal women has been implicated in increasing the risk of the following disorders except: A. Gall stones B. Osteoporosis C. Endometrial carcinoma D. Breast cancer

Description : Estrogen therapy in postmenopausal women has been implicated in increasing the risk of the following disorders except: A. Gall stones B. Osteoporosis C. Endometrial carcinoma D. Breast cancer

Last Answer : B. Osteoporosis

The following is true of raloxifene except: A. It acts as an estrogen agonist in bone B. It exerts estrogen antagonistic action on endometrium C. It increases risk of developing breast cancer D. It can induce/aggravate menopausal hot flushes

Description : The following is true of raloxifene except: A. It acts as an estrogen agonist in bone B. It exerts estrogen antagonistic action on endometrium C. It increases risk of developing breast cancer D. It can induce/aggravate menopausal hot flushes

Last Answer : C. It has additional androgenic acitivity

Which of the following is a selective estrogen receptor modulator that improves bone mineral density in postmenopausal women: A. Clomiphene citrate B. Raloxifene C. Ormeloxifene D. Alendronate

Description : Which of the following is a selective estrogen receptor modulator that improves bone mineral density in postmenopausal women: A. Clomiphene citrate B. Raloxifene C. Ormeloxifene D. Alendronate

Last Answer : B. Raloxifene

Tamoxifen citrate is used for palliative treatment of carcinoma breast in: A. Premenopausal women B. Postmenopausal women C. Mastectomized patients D. All of the above

Description : Tamoxifen citrate is used for palliative treatment of carcinoma breast in: A. Premenopausal women B. Postmenopausal women C. Mastectomized patients D. All of the above

Last Answer : D. All of the above

Select the correct statement about tibolone: A. It is an antiestrogen used for palliative treatment of carcinoma breast B. It is an estrogenic + progestational steroid used for hormone replacement therapy in postmenopausal women C. It is an antiandrogen used for male pattern baldness D. It is a nonsteroidal estrogen used topically for senile vaginitis

Description : Select the correct statement about tibolone: A. It is an antiestrogen used for palliative treatment of carcinoma breast B. It is an estrogenic + progestational steroid used for hormone replacement ... for male pattern baldness D. It is a nonsteroidal estrogen used topically for senile vaginitis

Last Answer : B. It is an estrogenic + progestational steroid used for hormone replacement therapy in postmenopausal women

Benefits of tamoxifen citrate therapy include the following except: A. Reduction in recurrence rate of breast cancer B. Improved bone mass C. Suppression of menopausal hot flushes D. Improved lipid profile

Description : Benefits of tamoxifen citrate therapy include the following except: A. Reduction in recurrence rate of breast cancer B. Improved bone mass C. Suppression of menopausal hot flushes D. Improved lipid profile

Last Answer : C. Suppression of menopausal hot flushes

Choose the selective estrogen receptor modulator that is useful in dysfunctional uterine bleeding by acting as estrogen antagonist in endometrium, but does not alter vaginal epithelium or cervical mucus: A. Ormeloxifene B. Tamoxifen C. Centchroman D. Danazol

Description : Choose the selective estrogen receptor modulator that is useful in dysfunctional uterine bleeding by acting as estrogen antagonist in endometrium, but does not alter vaginal epithelium or cervical mucus: A. Ormeloxifene B. Tamoxifen C. Centchroman D. Danazol

Last Answer : . Ormeloxifen

What is true of docetaxel: A. It is used as a reserve drug for refractory breast and ovarian cancer B. It is a selective estrogen receptor modulator used for breast cancer C. It is effective only in estrogen receptor positive breast cancer D. Both 'B' and 'C' are correct

Description : What is true of docetaxel: A. It is used as a reserve drug for refractory breast and ovarian cancer B. It is a selective estrogen receptor modulator used for breast cancer C. It is effective only in estrogen receptor positive breast cancer D. Both 'B' and 'C' are correct

Last Answer : A. It is used as a reserve drug for refractory breast and ovarian cancer

Select the compound which used for hormone replacement therapy in postmenopausal women serves the purpose of both estrogen and progestin with weak androgenic activity: A. Tibolone B. Mestranol C. Desogestrel D. Gestodene

Description : Select the compound which used for hormone replacement therapy in postmenopausal women serves the purpose of both estrogen and progestin with weak androgenic activity: A. Tibolone B. Mestranol C. Desogestrel D. Gestodene

Last Answer : A. Tibolone

Estrogen replacement therapy for postmenopausal women is contraindicated in subjects with: A. Leg vein thrombosis B. Undiagnosed vaginal bleeding C. Migraine D. All of the above

Description : Estrogen replacement therapy for postmenopausal women is contraindicated in subjects with: A. Leg vein thrombosis B. Undiagnosed vaginal bleeding C. Migraine D. All of the above

Last Answer : D. All of the above

The daily dose of estrogen for hormone replacement therapy in postmenopausal women is: A. Same as for contraception B. Higher than that for contraception C. Lower than that for contraception D. Variable depending on the age of the woman

Description : The daily dose of estrogen for hormone replacement therapy in postmenopausal women is: A. Same as for contraception B. Higher than that for contraception C. Lower than that for contraception D. Variable depending on the age of the woman

Last Answer : C. Lower than that for contraception

Addition of a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women is recommended because the progestin: A. Blocks the increased risk of myocardial infarction due to estrogen B. Blocks the increased risk of endometrial carcinoma due to estrogen C. Reverses vulval atrophy occurring in postmenopausal women D. Enhances the metabolic benefits of estrogen treatment

Description : Addition of a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women is recommended because the progestin: A. Blocks the increased risk of myocardial ... vulval atrophy occurring in postmenopausal women D. Enhances the metabolic benefits of estrogen treatment

Last Answer : The estrogen commonly used for hormone replacement therapy in menopausal women is: A. Ethinylestradiol B. Estradiol benzoate C. Diethylstilbestrol D. Conjugated estrogens

In a normal pregnant woman, the amount of total gonadotropin activity was assessed. The result expected was (1) High level of circulating HCG to stimulate estrogen and progesterone synthesis (2) High level of circulating FSH and LH in the uterus to stimulate implantation of the embryo (3) High level of circulating HCG to stimulate endometrial thickening (4) High levels of FSH and LH in uterus to stimulate endometrial thickening

Description : In a normal pregnant woman, the amount of total gonadotropin activity was assessed. The result expected was (1) High level of circulating HCG to stimulate estrogen and progesterone synthesis (2) ... endometrial thickening (4) High levels of FSH and LH in uterus to stimulate endometrial thickening

Last Answer : (1) High level of circulating HCG to stimulate estrogen and progesterone synthesis

Actions of progesterone include the following except: A. Rise in body temperature B. Endometrial proliferation C. Proliferation of acini in mammary gland D. Suppression of cell mediated immunity

Description : Actions of progesterone include the following except: A. Rise in body temperature B. Endometrial proliferation C. Proliferation of acini in mammary gland D. Suppression of cell mediated immunity

Last Answer : B. Endometrial proliferatio

What is true of thalidomide: A. It exerts antitumour activity in some solid malignant tumours B. It ameliorates cancer associated cachexia C. It exerts antileprotic action D. All of the above

Description : What is true of thalidomide: A. It exerts antitumour activity in some solid malignant tumours B. It ameliorates cancer associated cachexia C. It exerts antileprotic action D. All of the above

Last Answer : B. It ameliorates cancer associated cachexia

The purpose/purposes served by the progestin component of the combined estrogen + progestin contraceptive pill is/are: A. Suppression of ovulation B. Prompt bleeding at the end of the course C. Blockade of increased risk of endometrial carcinoma D. All of the above

Description : The purpose/purposes served by the progestin component of the combined estrogen + progestin contraceptive pill is/are: A. Suppression of ovulation B. Prompt bleeding at the end of the course C. Blockade of increased risk of endometrial carcinoma D. All of the above

Last Answer : D. All of the above

Addition of a progestin for 10-12 days every month to cyclic estrogen replacement therapy during menopause is recommended because the progestin: A. Prevents osteoporosis B. Prevents irregular bleeding C. Blocks increased risk of endometrial carcinoma D. Both ‘B’ and ‘C’ are correct

Description : Addition of a progestin for 10-12 days every month to cyclic estrogen replacement therapy during menopause is recommended because the progestin: A. Prevents osteoporosis B. Prevents irregular bleeding C. Blocks increased risk of endometrial carcinoma D. Both ‘B’ and ‘C’ are correct

Last Answer : D. Both ‘B’ and ‘C’ are correct

Health benefits afforded by the combined estrogenprogestin oral contraceptive pill include the following except: A. Reduced menstrual blood loss B. Lower risk of fibrocystic breast disease C. Lower risk of myocardial infarction D. Lower risk of endometrial carcinoma

Description : Health benefits afforded by the combined estrogenprogestin oral contraceptive pill include the following except: A. Reduced menstrual blood loss B. Lower risk of fibrocystic breast disease C. Lower risk of myocardial infarction D. Lower risk of endometrial carcinoma

Last Answer : . Lower risk of myocardial infarction

The primary indication of tamoxiphen citrate is: A. Female infertility B. Endometrial carcinoma C. Carcinoma breast D. Endometriosis

Description : The primary indication of tamoxiphen citrate is: A. Female infertility B. Endometrial carcinoma C. Carcinoma breast D. Endometriosis

Last Answer : C. Carcinoma breast

Estrogens are palliative in the following malignancy: A. Carcinoma breast B. Carcinoma cervix C. Endometrial carcinoma D. Carcinoma prostate

Description : Estrogens are palliative in the following malignancy: A. Carcinoma breast B. Carcinoma cervix C. Endometrial carcinoma D. Carcinoma prostate

Last Answer : D. Carcinoma prostate

Agonists affect the receptor molecule in the following manner: A. Alter its amino acid sequence B. Denature the receptor protein C. Alter its folding or alignment of subunits D. Induce covalent bond formation

Description : Agonists affect the receptor molecule in the following manner: A. Alter its amino acid sequence B. Denature the receptor protein C. Alter its folding or alignment of subunits D. Induce covalent bond formation

Last Answer : C. Alter its folding or alignment of subunits

Which of the following is true of acarbose: A. It reduces absorption of glucose from intestines B. It produces hypoglycaemia in normal as well as diabetic subjects C. It limits postprandial hyperglycaemia in diabetics D. It raises circulating insulin levels

Description : Which of the following is true of acarbose: A. It reduces absorption of glucose from intestines B. It produces hypoglycaemia in normal as well as diabetic subjects C. It limits postprandial hyperglycaemia in diabetics D. It raises circulating insulin levels

Last Answer : C. It limits postprandial hyperglycaemia in diabetics

The following is true of bezafibrate except: A. It activates lipoprotein lipase B. It mainly lowers serum triglyceride level with smaller effect on LDL cholesterol level C. It increases the incidence of myopathy due to statins D. It tends to lower plasma fibrinogen level

Description : The following is true of bezafibrate except: A. It activates lipoprotein lipase B. It mainly lowers serum triglyceride level with smaller effect on LDL cholesterol level C. It increases the incidence of myopathy due to statins D. It tends to lower plasma fibrinogen level

Last Answer : C. It increases the incidence of myopathy due to statins

The following is true of simvastatin except: A. It is more potent than lovastatin B. At the highest recommended dose, it causes greater LDL-cholesterol lowering than lovastatin C. It does not undergo first pass metabolism in liver D. It can raise HDL-cholesterol level when the same is low at base line

Description : The following is true of simvastatin except: A. It is more potent than lovastatin B. At the highest recommended dose, it causes greater LDL-cholesterol lowering than lovastatin C. It does not undergo ... metabolism in liver D. It can raise HDL-cholesterol level when the same is low at base line

Last Answer : C. It does not undergo first pass metabolism in liver

Mifepristone possesses the following activities: A. Potent antiprogestin + weak androgenic B. Potent antiprogestin + weak antiglucocorticoid C. Potent antiestrogenic + weak antiprogestin D. Potent antiestrogenic + weak glucocorticoid

Description : Mifepristone possesses the following activities: A. Potent antiprogestin + weak androgenic B. Potent antiprogestin + weak antiglucocorticoid C. Potent antiestrogenic + weak antiprogestin D. Potent antiestrogenic + weak glucocorticoid

Last Answer : Mifepristone possesses the following activities: A. Potent antiprogestin + weak androgenic B. Potent antiprogestin + weak antiglucocorticoid C. Potent antiestrogenic + weak antiprogestin D. Potent antiestrogenic + weak glucocorticoid

The following is true of loperamide except: A. It is absorbed from intestines and exerts centrally mediated antidiarrhoeal action B. It acts on the opioid receptors in the gut C. It increases tone and segmenting activity of the intestines D. It inhibits intestinal secretion by binding to calmodulin in the mucosal cells

Description : The following is true of loperamide except: A. It is absorbed from intestines and exerts centrally mediated antidiarrhoeal action B. It acts on the opioid receptors in the gut C. It increases ... of the intestines D. It inhibits intestinal secretion by binding to calmodulin in the mucosal cells

Last Answer : A. It is absorbed from intestines and exerts centrally mediated antidiarrhoeal action

Ideal HDL and LDL Cholesterol Levels for Men and Women?

Description : Ideal HDL and LDL Cholesterol Levels for Men and Women?

Last Answer : It seems one of the hottest topics among health-related publications is cholesterol, and the importance of keeping your cholesterol levels in check. But what is cholesterol, and what ... substantially increases the risk of developing adverse cardiovascular health problems in both men and women.

The rate limiting step in cholesterol biosynthesis is one of the followings : (A) LDL-receptor concentration (B) VLDL secretion (C) Mevalonic acid formation (D) Co-enzyme A formation

Description : The rate limiting step in cholesterol biosynthesis is one of the followings : (A) LDL-receptor concentration (B) VLDL secretion (C) Mevalonic acid formation (D) Co-enzyme A formation

Last Answer : (C) Mevalonic acid formation

Specific drug therapy to lower serum triglycerides (TG) in a subject with normal LDL-cholesterol level is indicated: A. In all subjects with serum TG> 150 mg/dl B. In subjects with existing coronary artery disease and serum TG > 150 mg/dl C. In subjects with HDL-cholesterol < 40 mg/dl and serum TG > 150 mg/dl D. Both 'B' and 'C' are correct

Description : Specific drug therapy to lower serum triglycerides (TG) in a subject with normal LDL-cholesterol level is indicated: A. In all subjects with serum TG> 150 mg/dl B. In subjects with existing coronary artery disease and serum TG ... < 40 mg/dl and serum TG > 150 mg/dl D. Both 'B' and 'C' are correct

Last Answer : D. Both 'B' and 'C' are correct

Gemfibrozil has the following features except: A. It lowers plasma LDL cholesterol to a greater extent than triglycerides B. It tends to raise plasma HDL-cholesterol level C. It is a first line drug for type III, type IV and type V hyperlipoproteinemia D. It reduces the incidence of myocardial infarctio

Description : Gemfibrozil has the following features except: A. It lowers plasma LDL cholesterol to a greater extent than triglycerides B. It tends to raise plasma HDL-cholesterol level C. It is a first ... type III, type IV and type V hyperlipoproteinemia D. It reduces the incidence of myocardial infarctio

Last Answer : A. It lowers plasma LDL cholesterol to a greater extent than triglycerides

Features of atorvastatin include the following: A. Dose to dose most potent HMG-CoA reductase inhibitor B. Higher ceiling of LDL-cholesterol lowering action than lovastatin C. Antioxidant property D. All of the above

Description : Features of atorvastatin include the following: A. Dose to dose most potent HMG-CoA reductase inhibitor B. Higher ceiling of LDL-cholesterol lowering action than lovastatin C. Antioxidant property D. All of the above

Last Answer : D. All of the above

Select the drug which reduces cholesterol synthesis in liver, increases expression of LDL receptors on hepatocytes and has been found to reduce mortality due to coronary artery disease: A. Simvastatin B. Nicotinic acid C. Gemfibrozil D. Colestipol (p. 577, 578) 43.1 4 3 . 1 D 43.2 4 3 . 2 C 43.3 4 3 . 3 A 43.4 4 3 . 4 A Ai

Description : Select the drug which reduces cholesterol synthesis in liver, increases expression of LDL receptors on hepatocytes and has been found to reduce mortality due to coronary artery disease: A. Simvastatin B. Nicotinic acid C. Gemfibrozil D. Colestipol (

Last Answer : A. Simvastatin

Select the most appropriate hypolipidemic drug for a patient with raised LDL-cholesterol level but normal triglyceride level: A. A HMG-CoA reductase inhibitor B. A fibric acid derivative C. Gugulipid D. Nicotinic acid

Description : Select the most appropriate hypolipidemic drug for a patient with raised LDL-cholesterol level but normal triglyceride level: A. A HMG-CoA reductase inhibitor B. A fibric acid derivative C. Gugulipid D. Nicotinic acid

Last Answer : A. A HMG-CoA reductase inhibitor

n addition to counteracting potassium loss, triamterene also opposes the following consequence of thiazide/furosemide therapy: A. Hyperuricaemia B. Rise in plasma LDL-cholesterol C. Magnesium loss D. Both ‘A’ and ‘C’ are correct

Description : n addition to counteracting potassium loss, triamterene also opposes the following consequence of thiazide/furosemide therapy: A. Hyperuricaemia B. Rise in plasma LDL-cholesterol C. Magnesium loss D. Both ‘A’ and ‘C’ are correct

Last Answer : C. Magnesium loss

Metabolic actions of estrogens tend to cause the following except: A. Anabolism B. Impaired glucose tolerance C. Rise in plasma LDL-cholesterol D. Salt and water retention

Description : Metabolic actions of estrogens tend to cause the following except: A. Anabolism B. Impaired glucose tolerance C. Rise in plasma LDL-cholesterol D. Salt and water retention

Last Answer : C. Rise in plasma LDL-cholesterol

In parkinsonian patients levodopa exerts the following effects except: A. Reduces skeletal muscle contractility B. Decreases muscle tone C. Increases locomotor activity D. Inhibits muscle tremor

Description : In parkinsonian patients levodopa exerts the following effects except: A. Reduces skeletal muscle contractility B. Decreases muscle tone C. Increases locomotor activity D. Inhibits muscle tremor

Last Answer : A. Reduces skeletal muscle contractility

Hyoscine differs from atropine in that it: A. Exerts depressant effects on the CNS at relatively low doses B. Exerts more potent effects on the heart than on the eye C. Is longer acting D. Has weaker antimotion sickness activity

Description : Hyoscine differs from atropine in that it: A. Exerts depressant effects on the CNS at relatively low doses B. Exerts more potent effects on the heart than on the eye C. Is longer acting D. Has weaker antimotion sickness activity

Last Answer : A. Exerts depressant effects on the CNS at relatively low doses

Which of the following drugs is an antiprogestin: A. Gemeprost B. Megestrol C. Mifepristone D. Tamoxifen

Description : Which of the following drugs is an antiprogestin: A. Gemeprost B. Megestrol C. Mifepristone D. Tamoxifen

Last Answer : C. Mifepristone

What is true of risperidone: A. It is an atypical neuroleptic which produces few extrapyramidal side effects B. It has combined dopamine D2 and 5-HT2 receptor blocking activity C. It does not cause hyperprolactinemia D. Both 'A' and 'B' are correct

Description : What is true of risperidone: A. It is an atypical neuroleptic which produces few extrapyramidal side effects B. It has combined dopamine D2 and 5-HT2 receptor blocking activity C. It does not cause hyperprolactinemia D. Both 'A' and 'B' are correct

Last Answer : D. Both 'A' and 'B' are correct

All of the following statements concerning the actinomycetous filamentous soil bacterium Frankia are correct except that Frankia (a) can induce root nodules on many plant species (b) can fix nitrogen in the free-living state (c) cannot fix specialized vesicles in which the nitrogenase is protected from oxygen by a chemical barrier involving triterpene hopanoids (d) like Rhizobium, it usually infects its host plant through root hair deformation and stimulates cell proliferation in the host’s cortex

Description : All of the following statements concerning the actinomycetous filamentous soil bacterium Frankia are correct except that Frankia (a) can induce root nodules on many plant species (b) can fix ... its host plant through root hair deformation and stimulates cell proliferation in the host's cortex

Last Answer : (b) can fix nitrogen in the free-living state

The following is true of buprenorphine: A. It is an agonist-antagonist type of opioid analgesic B. Its subjective effects are different from those of morphine C. Naloxone is largely ineffective in reversing its effects D. It produces mydriasis

Description : The following is true of buprenorphine: A. It is an agonist-antagonist type of opioid analgesic B. Its subjective effects are different from those of morphine C. Naloxone is largely ineffective in reversing its effects D. It produces mydriasis

Last Answer : C. Naloxone is largely ineffective in reversing its effects

Lowering LDL Cholesterol Levels?

Description : Lowering LDL Cholesterol Levels?

Last Answer : If your LDL cholesterol levels are outside of the normal or optimal ranges, you should take steps to lower your LDL cholesterol levels. There are many ways to do this, but one of the easiest ways is ... lard, and meat. Stick with canola or olive oil and choose vegetarian options a few days a week.

What is the difference between LDH and LDL cholesterol levels?

Description : What is the difference between LDH and LDL cholesterol levels?

Last Answer : LDL cholesterol levels are the calculation of bad levels in your body while HDL is considered to by the levels of good cholesterol in your body. Good cholesterol ratings can be maintained with proper exercise and diet.

Increased serum levels of which of the following may be associated with a decreased risk of atherosclerosis? (a) Very low-density lipoproteins (VLDL) (b) Low-density lipoproteins (LDL) (c) Intermediate – density lipoproteins (IDL) (d) High-density lipoproteins (HDL) (e) Cholesterol

Description : Increased serum levels of which of the following may be associated with a decreased risk of atherosclerosis? (a) Very low-density lipoproteins (VLDL) (b) Low-density lipoproteins (LDL) (c) Intermediate – density lipoproteins (IDL) (d) High-density lipoproteins (HDL) (e) Cholesterol

Last Answer : Ans: D

Select the progestin preparation for coadministration with estrogen for hormone replacement therapy that does not counteract the beneficial effect of the latter on lipid profile due to lack of androgenic activity: A. Micronized oral progesterone B. Norethindrone C. Lynestrenol D. Medroxyprogesterone acetate (p. 281-282)

Description : Select the progestin preparation for coadministration with estrogen for hormone replacement therapy that does not counteract the beneficial effect of the latter on lipid profile due to lack of ... oral progesterone B. Norethindrone C. Lynestrenol D. Medroxyprogesterone acetate (p. 281-282)

Last Answer : Select the indication for which a progestin is used alone without combining with an estrogen: A. Threatened abortion B. Dysfunctional uterine bleeding C. Hormone replacement therapy D. Premenstrual tension

What is true in relation to drug receptors: A. All drugs act through specific receptors B. All drug receptors are located on the surface of the target cells C. Agonists induce a conformational change in the receptor D. Partial agonists have low affinity for the receptor

Description : What is true in relation to drug receptors: A. All drugs act through specific receptors B. All drug receptors are located on the surface of the target cells C. Agonists induce a conformational change in the receptor D. Partial agonists have low affinity for the receptor

Last Answer : C. Agonists induce a conformational change in the receptoR

What is true in relation to drug receptors: A. All drugs act through specific receptors B. All drug receptors are located on the surface of the target cells C. Agonists induce a conformational change in the receptor D. Partial agonists have low affinity for the receptor

Description : What is true in relation to drug receptors: A. All drugs act through specific receptors B. All drug receptors are located on the surface of the target cells C. Agonists induce a conformational change in the receptor D. Partial agonists have low affinity for the receptor

Last Answer : C. Agonists induce a conformational change in the receptor

The following is/are true of mesalazine: A. It exerts mainly local antiinflammatory action in the lower gut B. It is a broad spectrum antidiarrhoeal drug C. It can be administered as a retention enema D. Both 'A' and 'C

Description : The following is/are true of mesalazine: A. It exerts mainly local antiinflammatory action in the lower gut B. It is a broad spectrum antidiarrhoeal drug C. It can be administered as a retention enema D. Both 'A' and 'C

Last Answer : D. Both 'A' and 'C

The following is true about actions of ethylalcohol: A. It exerts anticonvulsant action followed by lowering of seizure threshold B. It lowers pain threshold C. It increases confidence and reduces number of errors D. It increases heat production and helps to keep warm in cold weather

Description : The following is true about actions of ethylalcohol: A. It exerts anticonvulsant action followed by lowering of seizure threshold B. It lowers pain threshold C. It increases confidence and reduces number of errors D. It increases heat production and helps to keep warm in cold weather

Last Answer : A. It exerts anticonvulsant action followed by lowering of seizure threshold